Opinion: The Value of Collaborations in the Emerging and Developing World

Scientists can foster new talent, find new funding options, and tap into business opportunities by forging relationships between researchers in emerging, developing and developed nations.

Written byMohamed Boudjelal
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK, 13GOAT

There is no doubt that science is more advanced in Western institutions, followed by a few Asian countries. There is, at the same time, a plethora of skills, talents, and resources waiting to be explored in the emerging and developing world that could contribute to science innovation. The following are few ideas on how to forge such collaborations.

A number of research areas, such as infectious disease, rare conditions, and personalized medicine, need a tight collaboration between the scientists in developed, emerging, and developing countries. These diseases are more prominent in the emerging and developing world, and scientists there have developed unique skills to collect data and bank samples. For instance, many vaccines against viruses such as Ebola were jointly created by scientists of the developed world who provided the know-how and researchers in the emerging world who tested them on patients.

In collaboration with scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies